27.35 +0.13 (0.48%)
Pre-Market: 5:35AM EST
Previous Close | 36.31 |
Open | 31.76 |
Bid | 26.90 x 800 |
Ask | 28.61 x 1200 |
Day's Range | 26.35 - 33.25 |
52 Week Range | 17.00 - 50.90 |
Volume | 1,677,839 |
Avg. Volume | 591,590 |
Market Cap | 1.295B |
Beta (5Y Monthly) | 2.77 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Ladies and gentlemen, thank you for standing by and welcome to the Constellation Pharmaceuticals' Fourth Quarter 2020 Earnings Conference Call. Welcome to this conference call to discuss Constellation's fourth quarter 2020 financial results and operational performance.
Constellation Pharmaceuticals (CNST) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Every investor in Constellation Pharmaceuticals, Inc. (NASDAQ:CNST) should be aware of the most powerful shareholder...